Ditchcarbon
  • Customers
  1. Organizations
  2. Junshi Biosciences
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 12 days ago

Junshi Biosciences

Company website

Junshi Biosciences, officially known as Junshi Pharmaceutical Co., Ltd., is a leading biopharmaceutical company headquartered in China. Founded in 2012, the company has rapidly established itself in the global biotechnology landscape, focusing on the research, development, and commercialisation of innovative therapies, particularly in oncology and autoimmune diseases. With a strong presence in major operational regions including Asia and North America, Junshi Biosciences is recognised for its cutting-edge monoclonal antibody products. Notably, its flagship product, toripalimab, has garnered significant attention for its unique mechanism of action in cancer treatment. The company has achieved remarkable milestones, including successful partnerships and regulatory approvals, positioning itself as a key player in the biopharmaceutical industry.

DitchCarbon Score

How does Junshi Biosciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Junshi Biosciences's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.

22%

Let us know if this data was useful to you

Junshi Biosciences's reported carbon emissions

In 2024, Junshi Biosciences reported total carbon emissions of approximately 26,800,750 kg CO2e. This figure includes about 5,307,750 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and approximately 21,493,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Currently, Junshi Biosciences has not established any specific reduction targets or climate pledges, nor do they have emissions data for Scope 3, which encompasses all other indirect emissions that occur in a company's value chain. The absence of reduction initiatives indicates a potential area for future commitment to climate action. The emissions data is sourced directly from Shanghai Junshi Biosciences Co., Ltd., with no cascading from a parent or related organization. As the company continues to grow, it may consider setting science-based targets to align with global climate goals and enhance its sustainability profile.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2024
Scope 1
5,307,750
Scope 2
21,493,000
Scope 3
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Junshi Biosciences's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Junshi Biosciences is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Junshi Biosciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Guangzhou Gloria Biosciences Co., Ltd.

CN
Updated 18 days ago

Beigene

CN
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Lepu Medical Technology (Beijing) Co., Ltd.

CN
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Akeso

CN
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Hengrui Pharma

CN
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Innovent Biologics

CN
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250812.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy